$Arrowhead Pharmaceuticals (ARWR.US)$Log Chatter said, “People who are watching the situation have heard that Arrowhead Pharmaceuticals recently rejected the indicative policy of around $45 per share. “; Shares soared
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more